These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 5146426

  • 41. [A case of intolerance to the adrenergic alpha1 blockader prazosin].
    Shliakhto EV, Nedogoda SV, Nifontov EM, Pushkarev AA, Savushkin SN.
    Klin Med (Mosk); 1988 Nov; 66(11):135-7. PubMed ID: 3236799
    [No Abstract] [Full Text] [Related]

  • 42. [Reserpine-parkinsonoid syndrome in the chimpanzee and its treatment with fencamfamin].
    Müller-Calgan H, Sommer S.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 Nov; 260(2):177-8. PubMed ID: 4239211
    [No Abstract] [Full Text] [Related]

  • 43. Phenothiazine-induced dyskinesia in nursing-home patients.
    Greenblatt DL, Dominick JR, Stotsky BA, DiMascio A.
    J Am Geriatr Soc; 1968 Jan; 16(1):27-34. PubMed ID: 4863733
    [No Abstract] [Full Text] [Related]

  • 44. [The effect of reserpine on serotonin metabolism in patients with schizophrenia and reactive conditions].
    Zabrodin GD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974 Jan; 74(8):1185-91. PubMed ID: 4417086
    [No Abstract] [Full Text] [Related]

  • 45. Amantadine for dyskinesia tarda.
    Vale S, Espejel MA.
    N Engl J Med; 1971 Mar 25; 284(12):673. PubMed ID: 5545614
    [No Abstract] [Full Text] [Related]

  • 46. Persistent tardive dyskinesia.
    Carruthers SG.
    Br Med J; 1971 Sep 04; 3(5774):572. PubMed ID: 5106314
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Pseudotetanus following phenothiazine therapy].
    Matthes H, Andree G.
    Zentralbl Chir; 1968 Jan 27; 93(4):147-9. PubMed ID: 5658295
    [No Abstract] [Full Text] [Related]

  • 50. [Apomorphine in dyskinesia and psychomotor agitation].
    Stoliarov GV, Markova OF.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 Jan 27; 82(8):97-102. PubMed ID: 7136384
    [No Abstract] [Full Text] [Related]

  • 51. [Collateral effects of therapy with L-dopa in Parkinson's disease].
    Gomirato G, Perfetti CC, Ecari U.
    Sist Nerv; 1970 Jan 27; 22(2):67-73. PubMed ID: 5504559
    [No Abstract] [Full Text] [Related]

  • 52. [Facial dyskinesias caused by phenothiazine derivatives].
    De Oya JC, Alvarez Prechous A, Del Río A, Noya M, Ansede A.
    Rev Clin Esp; 1971 May 27; 121(4):357-60. PubMed ID: 5563111
    [No Abstract] [Full Text] [Related]

  • 53. Hypertension in older patients: what drugs to use and when.
    Caris TN.
    Geriatrics; 1982 Mar 27; 37(3):38-43. PubMed ID: 7067974
    [No Abstract] [Full Text] [Related]

  • 54. [Reconsideration of reserpine in the treatment of schizophrenia].
    Kubo S, Kodama H, Kimura N.
    Iryo; 1968 May 27; 22(5):578-82. PubMed ID: 5699914
    [No Abstract] [Full Text] [Related]

  • 55. Dyskinetic reactions to phenothiazine drugs and cryptotetany.
    Muller HR, Kaeser HE.
    Electroencephalogr Clin Neurophysiol; 1969 Jul 27; 27(1):106. PubMed ID: 4182869
    [No Abstract] [Full Text] [Related]

  • 56. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
    Fahn S.
    Adv Neurol; 1983 Jul 27; 37():267-76. PubMed ID: 6858776
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The significance of brain damage in persistent oral dyskinesia.
    Edwards H.
    Br J Psychiatry; 1970 Mar 27; 116(532):271-5. PubMed ID: 5418925
    [No Abstract] [Full Text] [Related]

  • 60. Drug-induced dyskinesia treated with intravenous diazepam.
    Schnell RG.
    J Fla Med Assoc; 1972 Jan 27; 59(1):22-3. PubMed ID: 5058953
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.